United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025.

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025 presents an indepth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most uptodate industry data on the actual market situation and future outlook for United States pneumococcal & meningococcal vaccines market. The report includes historical data from 2015 to 2018 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the United States pneumococcal & meningococcal vaccines market. The report also explores detailed analysis of top 6 vaccines market assessment in United States from 2015 to 2018 and forecasts to 2025. The report also details the latest information about the pneumococcal & meningococcal vaccines pricing trends and analysis. It also covers reimbursement pattern and offers a clear view of the regulatory landscape.

Additionally, the report includes assessment of promising vaccines in the clinical development by major companies. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive, licensing agreement and partnerships are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States pneumococcal & meningococcal vaccines market.

The report concludes with the profiles of major players in the United States pneumococcal & meningococcal vaccines market. The key market players are evaluated on various parameters such as business overview, vaccines portfolio and recent development.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Pfizer, Merck, Sanofi Pasteur and GlaxoSmithKline (GSK)

Top 6 Vaccines Covered Under This Report Are:

Prevnar / Prevnar 13
Pneumovax 23
Menactra
Bexsero
Menveo
Trumenba

The Latest Industry Data Included in this Report:

United States Pneumococcal & Meningococcal Vaccines Market Size & Analysis (2015 2025)
United States Pneumococcal Vaccines Market Size & Analysis (2015 2025)
United States Meningococcal Vaccines Market Size & Analysis (2015 2025)
United States Pneumococcal & Meningococcal Vaccines Market Share & YoY Growth (%), 2017 2025
United States Pneumococcal Vaccines Market Share & YoY Growth (%), 2015 2025
United States Meningococcal Vaccines Market Share & YoY Growth (%), 2017 2025
United States Pneumococcal & Meningococcal Vaccines Market Assessment & Opportunity (Value),2015 2025
United States Pneumococcal & Meningococcal Vaccines Pricing Trends & Analysis
United States Pneumococcal & Meningococcal Vaccines Reimbursement Policies
United States Pneumococcal & Meningococcal Vaccines Regulatory System
Promising Pneumococcal & Meningococcal Vaccines in Clinical Development
Major Deals in the Vaccines Market
Key Drivers and Inhibitors of the United States Pneumococcal & Meningococcal Vaccines Market
Major Companies Analysis

The Report Answers the Following Questions about the United States Pneumococcal & Meningococcal Vaccines Market:

What is the size of the United States pneumococcal & meningococcal vaccines market during 2015 2025?
What will be the revenue generated by each vaccine during the forecast period?
Which vaccine provides highest market share?
How are the overall market and vaccines type growing?
What are the key drivers and inhibitors in the current market?
What are the various pneumococcal & meningococcal vaccines available in the United States?
How is the market predicted to develop in the future?
Who are the key players in this market space?
1. Executive Summary
2. United States Pneumococcal & Meningococcal Vaccines Market Size & Analysis (2015 2025)
3. United States Pneumococcal Vaccines Market Size & Analysis (2015 2025)
4. United States Meningococcal Vaccines Market Size & Analysis (2015 2025)
5. United States Pneumococcal & Meningococcal Vaccines Market Share & YoY Growth (%), 2017 2025
5.1 United States Pneumococcal Vaccines Market Share & YoY Growth (%), 2015 2025
5.2 United States Meningococcal Vaccines Market Share & YoY Growth (%), 2017 2025
6. Key Drivers and Inhibitors of the United States Pneumococcal & Meningococcal Vaccines Market
6.1 Market Drivers
6.2 Market Inhibitors
7. United States Pneumococcal & Meningococcal Vaccines Market Assessment & Opportunity (Value),2015 2025
7.1 Prevnar / Prevnar 13
7.2 Pneumovax 23
7.3 Menactra
7.4 Bexsero
7.5 Menveo
7.6 Trumenba
8. United States Pneumococcal & Meningococcal Vaccines Pricing Trends & Analysis
9. United States Pneumococcal & Meningococcal Vaccines Reimbursement Policies & Regulatory System
9.1 Reimbursement Policies
9.2 Regulation System
10. Promising Pneumococcal & Meningococcal Vaccines in Clinical Development
11. Major Deals in the Vaccines Market
11.1 Merger & Acquisitions
11.2 Collaboration Deals
11.3 Licensing Agreement
11.4 Exclusive Agreement
11.5 Distribution Agreement
11.6 Partnerships
12. Key Companies Analysis
12.1 Sanofi Pasteur
12.1.1 Business Overview
12.1.2 Vaccines Portfolio
12.1.3 Recent Development
12.2 GlaxoSmithKline (GSK)
12.2.1 Business Overview
12.2.2 Vaccines Portfolio
12.2.3 Recent Development
12.3 Merck
12.3.1 Business Overview
12.3.2 Vaccines Portfolio
12.3.3 Recent Development
12.4 Pfizer
12.4.1 Business Overview
12.4.2 Vaccines Portfolio
12.4.3 Recent Development


List Of Tables



Table 51: United States Pneumococcal & Meningococcal Vaccines Market Share & YoY Growth (Percent), 2017 2018
Table 52: United States Pneumococcal & Meningococcal Vaccines Market Share & YoY Growth Forecast (Percent), 2019 2025
Table 53: United States Pneumococcal Vaccines Market Share & YoY Growth (Percent), 2015 2018
Table 54: United States Pneumococcal Vaccines Market Share & YoY Growth Forecast (Percent), 2019 2025
Table 55: United States Meningococcal Vaccines Market Share & YoY Growth (Percent), 2017 2018
Table 56: United States Meningococcal Vaccines Market Share & YoY Growth Forecast (Percent), 2019 2025
Table 81: United States Pneumococcal & Meningococcal Adult Vaccines Price, 2019 2020
Table 82: United States Pneumococcal & Meningococcal Pediatric Vaccines Price, 2019 2020
Table 91: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
Table 111: Merger & Acquisitions in the Vaccines Market
Table 112: Collaboration Deal in the Vaccines Market
Table 113: Licensing Agreement in the Vaccines Market
Table 114: Exclusive Agreement in the Vaccines Market
Table 115: Distribution Agreement in the Vaccines Market
Table 66: Partnerships in the Vaccines Market


List Of Figures



Figure 21: United States Pneumococcal & Meningococcal Vaccines Market Size(Million US$),2015 2018
Figure 22: United States Pneumococcal & Meningococcal Vaccines Market Size Forecast(Million US$),2019 2025
Figure 31: United States Pneumococcal Vaccines Market Size (Million US$),2015 2018
Figure 32: United States Pneumococcal Vaccines Market Size Forecast (Million US$),2019 2025
Figure 41: United States Meningococcal Vaccines Market Size (Million US$),2015 2018
Figure 42: United States Meningococcal Vaccines Market Size Forecast (Million US$),2019 2025
Figure 71: United States Prevnar/Prevnar 13 Market Value (Million US$),2015 2018
Figure 72: United States Prevnar/Prevnar 13 Market Value Forecast (Million US$),2019 2025
Figure 73: United States Pneumovax 23 Market Value (Million US$),2015 2018
Figure 74: United States Pneumovax 23 Market Value Forecast (Million US$),2019 2025
Figure 75: United States Menactra Market Value (Million US$),2015 2018
Figure 76: United States Menactra Market Value Forecast (Million US$),2019 2025
Figure 77: United States Bexsero Market Value (Million US$),2015 2018
Figure 78: United States Bexsero Market Value Forecast (Million US$),2019 2025
Figure 79: United States Menveo Market Value (Million US$),2015 2018
Figure 710: United States Menveo Market Value Forecast (Million US$),2019 2025
Figure 711: United States Trumenba Market Value (Million US$),2017 2018
Figure 712: United States Trumenba Market Value Forecast (Million US$),2019 2025


Ertapenem Global Market Review and Outlook by 2 Companies (Aurobindo, United Biotech etc.), by Application (Complex Abdominal Infection, Complex Skin and Soft Tissue Infection, Community Acquired Pneumonia, Complex Urinary Tract Infection)

Ertapenem report is in-depth investigation for Global market. Ertapenem market was valued at USD XX million Global in 2018 and is forecasted to reach USD XXX million by

USD 3000 View Report

United States Carrier Screening Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast to 2026

United States Carrier Screening Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast to 2026 market research report available in single user pdf license with Aarkstore Enterprise at USD 900

USD 900 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available